Arcutis Biotherapeutics Inc (ARQT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
9.12
-0.08
(-0.87%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value: 4.735 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.735 |
| May 16, 2024 | 4.694 |
| May 15, 2024 | 4.755 |
| May 14, 2024 | 4.184 |
| May 13, 2024 | 4.112 |
| May 10, 2024 | 4.035 |
| May 09, 2024 | 4.119 |
| May 08, 2024 | 4.104 |
| May 07, 2024 | 4.047 |
| May 06, 2024 | 4.083 |
| May 03, 2024 | 4.109 |
| May 02, 2024 | 4.417 |
| May 01, 2024 | 4.54 |
| April 30, 2024 | 4.273 |
| April 29, 2024 | 4.509 |
| April 26, 2024 | 4.35 |
| April 25, 2024 | 4.412 |
| April 24, 2024 | 4.494 |
| April 23, 2024 | 4.489 |
| April 22, 2024 | 4.591 |
| April 19, 2024 | 4.673 |
| April 18, 2024 | 4.852 |
| April 17, 2024 | 5.263 |
| April 16, 2024 | 5.186 |
| April 15, 2024 | 5.181 |
| Date | Value |
|---|---|
| April 12, 2024 | 5.238 |
| April 11, 2024 | 6.100 |
| April 10, 2024 | 6.336 |
| April 09, 2024 | 6.414 |
| April 08, 2024 | 6.434 |
| April 05, 2024 | 5.823 |
| April 04, 2024 | 5.52 |
| April 03, 2024 | 4.945 |
| April 02, 2024 | 4.827 |
| April 01, 2024 | 4.971 |
| March 31, 2024 | |
| March 28, 2024 | 12.85 |
| March 27, 2024 | 12.44 |
| March 26, 2024 | 12.02 |
| March 25, 2024 | 12.01 |
| March 22, 2024 | 12.46 |
| March 21, 2024 | 13.20 |
| March 20, 2024 | 14.00 |
| March 19, 2024 | 12.79 |
| March 18, 2024 | 13.27 |
| March 15, 2024 | 13.82 |
| March 14, 2024 | 14.19 |
| March 13, 2024 | 14.34 |
| March 12, 2024 | 13.11 |
| March 11, 2024 | 13.02 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.076
Minimum
Dec 14 2021
14.46
Maximum
Mar 08 2024
4.773
Average
4.422
Median
Sep 08 2020
Price to Book Value Benchmarks
| AdaptHealth Corp | 0.9094 |
| Prestige Consumer Healthcare Inc | 1.950 |
| Pfizer Inc | 1.759 |
| Adverum Biotechnologies Inc | 0.9155 |
| Karuna Therapeutics Inc (DELISTED) | 10.05 |
Price to Book Value Related Metrics
| PS Ratio | 7.070 |
| Price | 9.20 |
| Earnings Yield | -31.85% |
| Market Cap | 1.065B |